0000899243-23-010999.txt : 20230410
0000899243-23-010999.hdr.sgml : 20230410
20230410103945
ACCESSION NUMBER: 0000899243-23-010999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230406
FILED AS OF DATE: 20230410
DATE AS OF CHANGE: 20230410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klencke Barbara
CENTRAL INDEX KEY: 0001647647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 23810043
MAIL ADDRESS:
STREET 1: C/O SIERRA ONCOLOGY, INC.
STREET 2: 1820 GATEWAY DRIVE, SUITE 110
CITY: SAN MATEO
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-06
0
0001783328
TScan Therapeutics, Inc.
TCRX
0001647647
Klencke Barbara
C/O TSCAN THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
1
0
0
0
0
Stock Option (Right to Buy)
2.20
2023-04-06
4
A
0
9146
0.00
A
2033-04-05
Voting Common Stock
9146
9146
D
The shares subject to this option shall vest and become exercisable in thirty-six equal monthly installments following April 6, 2023, subject to the Reporting Person's continued service at such time.
/s/ Barbara Klencke
2023-04-10